Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL
2011

How BCR-ABL Kinase Activity Affects Nuclear Import in Chronic Myeloid Leukemia

publication Evidence: moderate

Author Information

Author(s): Martin Preyer, Paolo Vigneri, Jean Y. J. Wang

Primary Institution: University of California San Diego School of Medicine

Hypothesis

The study investigates how the BCR-ABL kinase activity regulates its nuclear localization signals (NLS) and the role of specific tyrosine mutations in this process.

Conclusion

The study concludes that specific tyrosine mutations in the BCR-ABL kinase domain can inhibit its nuclear import, and that the conformation of the kinase domain is critical for regulating this process.

Supporting Evidence

  • Mutations in specific tyrosines of BCR-ABL can block its nuclear import.
  • Imatinib binding can restore the nuclear localization signal function.
  • The F-actin binding domain is involved in the regulation of BCR-ABL nuclear import.

Takeaway

This study shows that certain changes in a protein related to leukemia can stop it from going into the cell's nucleus, which is important for its function.

Methodology

The study used mutant BCR-ABL proteins and examined their localization under various treatments to assess the role of specific tyrosines and the F-actin binding domain.

Digital Object Identifier (DOI)

10.1371/journal.pone.0017020

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication